The Impact of COVID-19 on the Health-Care Workforce: from Heroes to Zeroes?

由 Czernin, Johannes
發表在 J Nucl Med (2020)

Is conflict of interest in our best interest?

由 Beyer, Thomas, Czernin, Johannes
出版 2010

The Potential of PET/MRI Imaging in Oncology: a Comment to a Summary Report of the First PET/MRI Workshop in Tuebingen in 2012

由 Czernin, Johannes, Herrmann, Ken
出版 2013

A Conversation Between Nora Volkow and Johannes Czernin

由 Volkow, Nora, Czernin, Johannes
發表在 J Nucl Med (2019)

Molecular Mechanisms of Bone (18)F-NaF Deposition

由 Czernin, Johannes, Satyamurthy, Nagichettiar, Schiepers, Christiaan
出版 2010

(18)F-FDG PET/CT and PET/MRI Perform Equally Well in Cancer: Evidence from Studies on More Than 2,300 Patients

由 Spick, Claudio, Herrmann, Ken, Czernin, Johannes
發表在 J Nucl Med (2016)

PET Imaging of Prostate Cancer Using (11)C-Acetate

由 Czernin, Johannes, Benz, Matthias R., Allen-Auerbach, Martin S.
出版 2009

Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer

由 Lee, Percy, Kupelian, Patrick, Czernin, Johannes, Ghosh, Partha
出版 2012

The future of hybrid imaging—part 3: PET/MR, small-animal imaging and beyond

由 Beyer, Thomas, Freudenberg, Lutz S., Czernin, Johannes, Townsend, David W.
出版 2011

The future of hybrid imaging—part 1: hybrid imaging technologies and SPECT/CT

由 Beyer, Thomas, Freudenberg, Lutz S., Townsend, David W., Czernin, Johannes
出版 2011

The future of hybrid imaging—part 2: PET/CT

由 Beyer, Thomas, Townsend, David W., Czernin, Johannes, Freudenberg, Lutz S.
出版 2011

PET/CT in Oncology: Current Status and Perspectives

由 Czernin, Johannes, Allen-Auerbach, Martin, Nathanson, David, Herrmann, Ken
出版 2013

Variations in PET/MRI Operations: Results from an International Survey Among 39 Active Sites

由 Fendler, Wolfgang Peter, Czernin, Johannes, Herrmann, Ken, Beyer, Thomas
發表在 J Nucl Med (2016)

Positron Emission Tomography Reporter Genes and Reporter Probes: Gene and Cell Therapy Applications

由 Yaghoubi, Shahriar S., Campbell, Dean O., Radu, Caius G., Czernin, Johannes
出版 2012

Technology Insight: novel imaging of molecular targets is an emerging area crucial to the development of targeted drugs

由 Weber, Wolfgang A, Czernin, Johannes, Phelps, Michael E, Herschman, Harvey R
出版 2008

Stratification of Nucleoside Analog Chemotherapy Using 1-(2′-Deoxy-2′-(18)F-Fluoro-β-D-Arabinofuranosyl)Cytosine and 1-(2′-Deoxy-2′-(18)F-Fluoro-β-L-Arabinofuranosyl)-5-Methylcytos...

由 Lee, Jason T., Campbell, Dean O., Satyamurthy, Nagichettiar, Czernin, Johannes, Radu, Caius G.
出版 2012

Clinical use of bone-targeting radiopharmaceuticals with focus on alpha-emitters

由 Wieder, Hinrich A, Lassmann, Michael, Allen-Auerbach, Martin S, Czernin, Johannes, Herrmann, Ken
出版 2014

NI-68 (18)F-FDOPA PET IN TREATED LOW-GRADE GLIOMAS WITH NON-ENHANCING T2 CHANGES ON MRI IS PROGNOSTIC OF TUMOR PROGRESSION AND OVERALL SURVIVAL

由 Schwarzenberg, Johannes, Czernin, Johannes, Cloughesy, Timothy, Lai, Albert, Phelps, Michael, Chen, Wei
出版 2014

Absolute Quantitation of Myocardial Blood Flow in Human Subjects with or without Myocardial Ischemia using Dynamic Flurpiridaz F 18 Positron Emission Tomography

由 Packard, René R. S., Huang, Sung-Cheng, Dahlbom, Magnus, Czernin, Johannes, Maddahi, Jamshid
發表在 J Nucl Med (2014)

Correction to: Randomized prospective phase III trial of 68Ga-PSMA-11 PET/CT molecular imaging for prostate cancer salvage radiotherapy planning [PSMA-SRT]

由 Calais, Jeremie, Czernin, Johannes, Fendler, Wolfgang P., Elashoff, David, Nickols, Nicholas G.
發表在 BMC Cancer (2019)